Past, present, and future of radiotherapy for the benefit of patients

被引:311
作者
Thariat, Juliette [1 ]
Hannoun-Levi, Jean-Michel [1 ]
Myint, Arthur Sun [2 ]
Te Vuong [3 ]
Gerard, Jean-Pierre [1 ]
机构
[1] Univ Nice Sophia Antipolis, Ctr Antoine Lacassagne, Dept Radiat Oncol, F-06189 Nice, France
[2] Clatterbridge Canc Ctr NHS Fdn Trust, Brachytherapy Unit, Liverpool L9 7BA, Merseyside, England
[3] McGill Univ, Hop Gen Juif, Dept Radiat Oncol, Montreal, PQ H3T 1E2, Canada
关键词
INTENSITY-MODULATED RADIOTHERAPY; LOCALIZED PROSTATE-CANCER; PROTON-BEAM RADIOTHERAPY; X-RAY THERAPY; RADIATION-THERAPY; PREOPERATIVE RADIOTHERAPY; RECTAL-CANCER; CONFORMAL RADIOTHERAPY; POSTOPERATIVE CHEMORADIOTHERAPY; INTRAOPERATIVE RADIOTHERAPY;
D O I
10.1038/nrclinonc.2012.203
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Radiotherapy has been driven by constant technological advances since the discovery of X-rays in 1895. Radiotherapy aims to sculpt the optimal isodose on the tumour volume while sparing normal tissues. The benefits are threefold: patient cure, organ preservation and cost-efficiency. The efficacy and tolerance of radiotherapy were demonstrated by randomized trials in many different types of cancer (including breast, prostate and rectum) with a high level of scientific evidence. Such achievements, of major importance for the quality of life of patients, have been fostered during the past decade by linear accelerators with computer-assisted technology. More recently, these developments were augmented by proton and particle beam radiotherapy, usually combined with surgery and medical treatment in a multidisciplinary and personalized strategy against cancer. This article reviews the timeline of 100 years of radiotherapy with a focus on breakthroughs in the physics of radiotherapy and technology during the past two decades, and the associated clinical benefits. Thariat, J. et al. Nat. Rev. Clin. Oncol. 10, 52-60 (2013); published online 27 November 2012; doi:10.1038/nrclinonc.2012.203
引用
收藏
页码:52 / 60
页数:9
相关论文
共 117 条
[1]  
[Anonymous], 1971, PHYS MED BIOL, V16, P379
[2]   Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial [J].
Aschele, Carlo ;
Cionini, Luca ;
Lonardi, Sara ;
Pinto, Carmine ;
Cordio, Stefano ;
Rosati, Gerardo ;
Artale, Salvatore ;
Tagliagambe, Angiolo ;
Ambrosini, Giovanni ;
Rosetti, Paola ;
Bonetti, Andrea ;
Negru, Maria Emanuela ;
Tronconi, Maria Chiara ;
Luppi, Gabriele ;
Silvano, Giovanni ;
Corsi, Domenico Cristiano ;
Bochicchio, Anna Maria ;
Chiaulon, Germana ;
Gallo, Maurizio ;
Boni, Luca .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (20) :2773-2780
[3]  
Baclesse F, 1967, Clin Radiol, V18, P292, DOI 10.1016/S0009-9260(67)80077-1
[4]   Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. [J].
Bartelink, H ;
Horiot, J ;
Poortmans, P ;
Struikmans, H ;
Van den Bogaert, W ;
Barillot, I ;
Fourquet, A ;
Borger, J ;
Jager, J ;
Hoogenraad, W ;
Collette, L ;
Pierart, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (19) :1378-1387
[5]   70 GY VERSUS 80 GY IN LOCALIZED PROSTATE CANCER: 5-YEAR RESULTS OF GETUG 06 RANDOMIZED TRIAL [J].
Beckendorf, Veronique ;
Guerif, Stephane ;
Le Prise, Elisabeth ;
Cosset, Jean-Marc ;
Bougnoux, Agnes ;
Chauvet, Bruno ;
Salem, Naji ;
Chapet, Olivier ;
Bourdain, Sylvain ;
Bachaud, Jean-Marc ;
Maingon, Philippe ;
Hannoun-Levi, Jean-Michel ;
Malissard, Luc ;
Simon, Jean-Marc ;
Pommier, Pascal ;
Hay, Men ;
Dubray, Bernard ;
Lagrange, Jean-Leon ;
Luporsi, Elisabeth ;
Bey, Pierre .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (04) :1056-1063
[6]  
BECQUEREL J, 1948, NATURE, V161, P609, DOI 10.1038/161609b0
[7]  
Bergonié J, 1906, CR HEBD ACAD SCI, V143, P983
[8]   Timeline - Radiation oncology: a century of achievements [J].
Bernier, J ;
Hall, EJ ;
Giaccia, A .
NATURE REVIEWS CANCER, 2004, 4 (09) :737-U15
[9]   COMBINATION CHEMOTHERAPY AS AN ADJUVANT TREATMENT IN OPERABLE BREAST-CANCER [J].
BONADONNA, G ;
BRUSAMOLINO, E ;
VALAGUSSA, P ;
ROSSI, A ;
BRUGNATELLI, L ;
BRAMBILLA, C ;
DELENA, M ;
TANCINI, G ;
BAJETTA, E ;
MUSUMECI, R ;
VERONESI, U .
NEW ENGLAND JOURNAL OF MEDICINE, 1976, 294 (08) :405-410
[10]  
Borella L, 2002, B CANCER, V89, P809